Oskare Capital logo

Oskare Capital

Europe, Ile-de-France, France, Paris

Description

Headquartered in Paris and London, Óskare Capital specializes in venture-stage investments in the Deeptech and Life Sciences sectors.

Investor Profile

Oskare Capital has backed more than 7 startups, with 0 new investments in the last 12 months alone. The firm has led 4 rounds, about 57% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series A, Pre Seed rounds (top funding stages).
  • Majority of deals are located in Denmark, Italy, United Kingdom.
  • Strong thematic focus on Biotechnology, Health Care, Bioinformatics.

Stage Focus

  • Seed (57%)
  • Series A (29%)
  • Pre Seed (14%)

Country Focus

  • Denmark (71%)
  • Italy (14%)
  • United Kingdom (14%)

Industry Focus

  • Biotechnology
  • Health Care
  • Bioinformatics
  • Biopharma
  • Medical
  • Wellness
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Oskare Capital frequently co-invest with?

Vaekstfonden
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 2
2420 Partners
North America, Massachusetts, United States, Boston
Co-Investments: 1
Unconventional Ventures
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 1
The Footprint Firm
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 1
DSM Venturing
Europe, Limburg, The Netherlands, Heerlen
Co-Investments: 2
EA
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 1

Which angels does Oskare Capital often collaborate with?

Bruce Linton
North America, Ontario, Canada, Ottawa
Shared Deals: 2

What are some of recent deals done by Oskare Capital?

Octarine Bio

Copenhagen, Hovedstaden, Denmark

Octarine Bio is a synthetic biology company that produces superior cannabinoids for the pharmaceutical industry.

BioinformaticsBiopharmaBiotechnologyHealth Care
Series AJan 22, 2026
Amount Raised: $5,858,835
Octarine Bio

Copenhagen, Hovedstaden, Denmark

Octarine Bio is a synthetic biology company that produces superior cannabinoids for the pharmaceutical industry.

BioinformaticsBiopharmaBiotechnologyHealth Care
Series ANov 8, 2023
Amount Raised: $4,659,438
Leva Clinic

London, England, United Kingdom

Leva Clinic provides treatment for back, joint, and knee pain.

Health CareMedicalWellness
SeedNov 4, 2022
Amount Raised: $3,411,417
Octarine Bio

Copenhagen, Hovedstaden, Denmark

Octarine Bio is a synthetic biology company that produces superior cannabinoids for the pharmaceutical industry.

BioinformaticsBiopharmaBiotechnologyHealth Care
SeedSep 20, 2022
Amount Raised: $1,994,251
Herbolea Biotech

Firenze, Toscana, Italy

Herbolea is a biotech company envisioning the use of innovative, green technologies to obtain safe, high-quality and natural products.

Biotechnology
Series AOct 26, 2021
Amount Raised: $5,798,251
Octarine Bio

Copenhagen, Hovedstaden, Denmark

Octarine Bio is a synthetic biology company that produces superior cannabinoids for the pharmaceutical industry.

BioinformaticsBiopharmaBiotechnologyHealth Care
SeedMar 11, 2021
Amount Raised: $1,200,000
Octarine Bio

Copenhagen, Hovedstaden, Denmark

Octarine Bio is a synthetic biology company that produces superior cannabinoids for the pharmaceutical industry.

BioinformaticsBiopharmaBiotechnologyHealth Care
SeedNov 12, 2020
Amount Raised: $1,800,000
Octarine Bio

Copenhagen, Hovedstaden, Denmark

Octarine Bio is a synthetic biology company that produces superior cannabinoids for the pharmaceutical industry.

BioinformaticsBiopharmaBiotechnologyHealth Care
Pre SeedJan 13, 2020

Find More Investors Like Oskare Capital

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Oskare Capital | Pipeseed